Anthropic’s R&D budget now rivals Eli Lilly’s
Anthropic's S-1 shows $9.74B of first-half R&D, more than any big U.S. drugmaker's ongoing R&D, and $14.2B over 12 months, near Eli Lilly's.
Anthropic's S-1 shows $9.74B of first-half R&D, more than any big U.S. drugmaker's ongoing R&D, and $14.2B over 12 months, near Eli Lilly's.